Loading the company…
Loading the company…
Families: Lumbar fusion, Debridement & negative-pressure wound therapy.
All companies · Product and company coverage
In the last ten years FDA made 3 decisions for Cg Bio (510(k) clearances, De Novo grants, PMA approvals and supplements) under the product codes MedaRep maps to 2 procedure families, the most in 2026 (1). The latest was on 2026-06-23.
| Family | Decisions on record |
|---|---|
| Lumbar fusion | 3 |
| Debridement & negative-pressure wound therapy | 2 |
| KULAVAC |
Decisions under the product codes mapped to the procedure families; devices filed under other codes are not here. Applicants are rolled up to Cg Bio.